Effects of Romantic Affection on Blood Chemistry and Immune Parameters

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
Arizona State University
ClinicalTrials.gov Identifier:
NCT00482404
First received: June 4, 2007
Last updated: NA
Last verified: June 2007
History: No changes posted
  Purpose

This trial tests the hypothesis that increasing nonverbal affection in romantic relationships will improve blood lipid parameters (total cholesterol, high and low density lipoproteins, triglycerides), blood glucose, and immune parameters (C-reactive protein and antibodies to latent Epstein-Barr virus). 52 healthy cohabiting romantic couples took part. In half of the couples, one partner increased the frequency of romantic kissing with the other partner during the six-week trial. The other couples received no such instruction. Blood tests performed before and after the trial were used to assess the health outcomes.


Condition Intervention Phase
Stress
Hypercholesterolemia
Behavioral: Romantic kissing
Phase 0

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind
Primary Purpose: Treatment
Official Title: Study of the Effects of Romantic Affection on Blood Lipids, Blood Glucose, C-Reactive Protein, and Antibodies to Latent Epstein-Barr Virus

Resource links provided by NLM:


Further study details as provided by Arizona State University:

Study Start Date: February 2007
Study Completion Date: May 2007
  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • 18+ years of age;
  • English-speaking;
  • Current co-habitation with romantic partner

Exclusion Criteria:

  • History of hypercholesterolemia;
  • Current pregnancy;
  • Current use of blood-thinning agents;
  • Greater than moderate anxiety about giving capillary blood;
  • Weight of less than 110 pounds
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00482404

Sponsors and Collaborators
Arizona State University
Investigators
Principal Investigator: Kory Floyd, PhD Arizona State University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00482404     History of Changes
Other Study ID Numbers: 1001 R03 MH075757-01A1
Study First Received: June 4, 2007
Last Updated: June 4, 2007
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Hypercholesterolemia
Hyperlipidemias
Dyslipidemias
Lipid Metabolism Disorders
Metabolic Diseases

ClinicalTrials.gov processed this record on September 16, 2014